Literature DB >> 11967821

Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts.

V V Petrov1, R H Fagard, P J Lijnen.   

Abstract

OBJECTIVES: Appearance of angiotensin-converting enzyme (ACE) in fibrotic tissue can be the result of the action either of one particular growth factor or of cross-talk between multiple factors. Transforming growth factor-beta1 (TGF-beta(1)) is an effective inducor of the differentiation of cultured fibroblasts to myofibroblasts, which are heterogeneous cells with different phenotypes. The present study investigated whether TGF-beta(1) is able to induce, in vitro, the differentiation of cultured fibroblasts to myofibroblasts with a phenotype containing ACE.
DESIGN: Adult rat cardiac ventricular fibroblasts were obtained from hearts perfused with collagenase. Cells from second passage were always used. Rat cardiac ventricular fibroblasts were incubated with TGF-beta(1) (10 ng/ml) for seven days. Cell characterisation was performed using light microscopy and indirect immunostaining. Presence of vimentin, desmin, factor VIII, alpha-smooth muscle actin, and ACE was checked with both immunostaining and Western blotting. ACE activity was measured fluorometrically with hippuryl-histidyl-leucine as substrate. Synthesis of DNA was measured as (3)H-thymidine incorporation.
RESULTS: Fibroblasts contained two types of activity of hip-his-leu degradation, namely a lisinopril-dependent activity (ACE activity) and a lisinopril-independent activity ('ACE-like' activity) which is performed by peptidase(s) other than ACE. The ACE activity constituted approximately 30% of the total activity. TGF-beta(1) induced an increase in both ACE activity and ACE protein (detected by immunoblotting) by 4.5 +/- 0.9- and 6.9 +/- 2.0-fold, respectively (p<0.05). This induction of ACE was accompanied by a profound modification of the fibroblasts phenotype, which consisted of a change in cell morphology, an enlargement of cell volume and an increase in cell protein content. TGF-beta(1) profoundly inhibited (3)H-thymidine incorporation and the number of cells in growing cultures. The induction of alpha-smooth muscle actin by TGF-beta(1) (6.8 +/- 2.8-fold increase, p<0.05) simultaneously with these modifications in cell morphology and proliferation indicates the appearance of myofibroblasts. These myofibroblasts did not contain desmin.
CONCLUSION: TGF-beta(1) is able to induce the appearance of ACE in cultures of adult rat cardiac ventricular fibroblasts. The appearance of the enzyme is accompanied by the differentiation of fibroblasts to myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11967821     DOI: 10.3317/jraas.2000.064

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  14 in total

Review 1.  The role of transforming growth factor β1 in the regulation of blood pressure.

Authors:  Kota Matsuki; Catherine K Hathaway; Marlon G Lawrence; Oliver Smithies; Masao Kakoki
Journal:  Curr Hypertens Rev       Date:  2014

2.  Local Renin-Angiotensin System Signaling Mediates Cellular Function of Aortic Valves.

Authors:  Asya Ozkizilcik; Fah Sysavanh; Smit Patel; Ishita Tandon; Kartik Balachandran
Journal:  Ann Biomed Eng       Date:  2021-10-26       Impact factor: 3.934

Review 3.  Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms.

Authors:  Xiaofeng Chen; Hong Lu; Debra L Rateri; Lisa A Cassis; Alan Daugherty
Journal:  Curr Opin Pharmacol       Date:  2013-03-12       Impact factor: 5.547

4.  TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.

Authors:  Michael A Hagler; Thomas M Hadley; Heyu Zhang; Kashish Mehra; Carolyn M Roos; Hartzell V Schaff; Rakesh M Suri; Jordan D Miller
Journal:  Cardiovasc Res       Date:  2013-04-03       Impact factor: 10.787

5.  Qindan capsule changes adventitial collagen synthesis in spontaneously hypertensive rats.

Authors:  Yi-jing Lv; Gui-lin Liu; Xu-ming Ji; Cun-zhong Yuan; Bo Wang; Min Ren; Lei Yan; Xu-ping Wang; Ji-dong Zhang
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978

Review 6.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

7.  In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.

Authors:  Qiang Shi; Xiaoyan Liu; Yuanyuan Bai; Chuanjue Cui; Jun Li; Yishi Li; Shengshou Hu; Yingjie Wei
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

8.  Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1.

Authors:  Zhi-Qiang Li; Ying-Long Liu; Gang Li; Bin Li; Yang Liu; Xiao-Feng Li; Ai-Jun Liu
Journal:  Mol Med Rep       Date:  2014-10-23       Impact factor: 2.952

Review 9.  Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease.

Authors:  Craig Wong; Peter Kanetsky; Dominic Raj
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714

10.  Reversible and irreversible differentiation of cardiac fibroblasts.

Authors:  Ronald B Driesen; Chandan K Nagaraju; Joëlle Abi-Char; Tamara Coenen; Paul J Lijnen; Robert H Fagard; Karin R Sipido; Victor V Petrov
Journal:  Cardiovasc Res       Date:  2013-12-23       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.